A 2010 study published in the Journal of the American Medical Association shows that women who take
Prempro are twice as likely to die from breast cancer(4) A study published the same year in Archives of Internal Medicine shows that women taking
Prempro or Premarin are also 21% more likely to develop kidney stones over (5) years.
Summary: Zoe Littlepage and Rainey Booth, two attorneys who sued Pfizer over
Prempro, a menopause drug, will reportedly get more than $21.
Elimination of sampling by Wyeth, and now exclusion from drug formularies with the attendant exorbitant increases in cost have, in addition to the absence of a defense by researchers or manufacturers, discouraged continuing use of this valuable medication, even among those in whom the safety and benefits of Premarin and
Prempro have been established over years of experience and scores of studies.
She has been lead trial counsel for cases involving
Prempro, Rezulin, Fen/Phen and other prescription medications.
But the study's adverse effects were seen in women who had not had hysterectomies and who were taking a specific treatment drug,
Prempro.
Hormone products containing estrogen that are not bioidentical, such as
Prempro, are made with mares' urine.
Ray reports that he has received financial support from Pfizer, was a paid expert witness in a lawsuit by the state of Texas against Merck, and is a paid expert in an insurance company action against the maker of
Prempro.
Not the breast cancer, not the heart disease, not the strokes or emboli linked to
Prempro.
His associates reported ties to Procter & Gamble, Wyeth Laboratories (maker of
Prempro used in the WHI), Upsher-Smith Laboratories, Meditrina Pharmaceuticals Inc.
The treatment studied was the most commonly prescribed hormone replacement pill,
Prempro, which contains estrogens from horse urine and a synthetic relative of the hormone progesterone.
A coauthor disclosed serving as an expert witness for plaintiffs pursuing
Prempro litigation.
The analysis revealed that Wyeth used ghostwritten reviews and commentaries published in medical journals to promote unproven benefits and downplay harms of
Prempro -- a brand of menopausal hormone therapy ( HT) -- and to cast competing therapies in a negative light.
